| __timestamp | Ionis Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 20140000 | 15746000 |
| Thursday, January 1, 2015 | 37173000 | 13392000 |
| Friday, January 1, 2016 | 48616000 | 9290000 |
| Sunday, January 1, 2017 | 108488000 | 7672000 |
| Monday, January 1, 2018 | 244622000 | 15293000 |
| Tuesday, January 1, 2019 | 287000000 | 22648000 |
| Wednesday, January 1, 2020 | 354000000 | 21864000 |
| Friday, January 1, 2021 | 186000000 | 37318000 |
| Saturday, January 1, 2022 | 151000000 | 48130000 |
| Sunday, January 1, 2023 | 232600000 | 108146000 |
| Monday, January 1, 2024 | 267474000 |
Igniting the spark of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Ionis Pharmaceuticals, Inc. and Madrigal Pharmaceuticals, Inc. have taken different paths in this regard over the past decade. From 2014 to 2023, Ionis Pharmaceuticals consistently reported higher SG&A expenses, peaking in 2020 with a staggering 354% increase from 2014. In contrast, Madrigal Pharmaceuticals maintained a more conservative approach, with their highest SG&A expenses in 2023, marking a 587% increase from 2014. Despite Ionis's higher absolute costs, their strategic investments in administration and sales might be driving their growth. Meanwhile, Madrigal's leaner approach could indicate a focus on operational efficiency. This comparison highlights the diverse strategies within the biotech sector, where financial management can significantly impact a company's trajectory.
Cost Management Insights: SG&A Expenses for Alnylam Pharmaceuticals, Inc. and Ionis Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Madrigal Pharmaceuticals, Inc.
Bio-Techne Corporation or Madrigal Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or CymaBay Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.
Madrigal Pharmaceuticals, Inc. and Geron Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. and Dynavax Technologies Corporation: SG&A Spending Patterns Compared
Madrigal Pharmaceuticals, Inc. or Viridian Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. vs Apellis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.